droplet-based PCR
Bio-Rad Laboratories, Stilla Technologies Settle IP Lawsuit
Bio-Rad had alleged Stilla's Naica digital PCR system infringed on four patents held or licensed by the firm.
10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit
10x asked the US District Court for the Northern District of California to dismiss a suit, while another district court judge denied a 10x motion to dismiss.
The new chip enables the firm's digital PCR system to test up to 240 samples per day, and also uses lower volumes of sample input.
Bio-Rad Shutters Former GnuBio Facility as Part of Digital Biology R&D Consolidation
The company acquired GnuBio, which was developing a droplet-based sequencing platform, in 2014 for $39.7 million in cash and $10 million in contingent payments.
Bio-Rad Q2 Revenues Fall 2 Percent
The sales decline was largely due to a slowdown in productivity related to the recent launch of the company's global enterprise resource planning system in Western Europe.
Sep 11, 2015
Apr 8, 2015
Jan 5, 2015
Feb 25, 2014